VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
KRYS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
KRYSKrystal Biotech, Inc.
$300.88$8.9B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksKRYSQuarterly Cash Flow

Krystal Biotech, Inc. (KRYS) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Krystal Biotech, Inc. (KRYS) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

KRYS Cash Flow Statement

Quarterly statement

KRYS Cash Flow Statement

Krystal Biotech, Inc. (KRYS) cash flow statement — 10-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Cash from Operations91.25M74.79M80.38M77.51M39.66M52.73M30.97M52.84M58.86M-4.17M15.89M-7.23M-21.23M-34.19M-26.16M-22.33M-19.69M-43.06M-15.49M-20.9M
Operating CF Margin %71.66%62.73%69.08%72.37%40.55%54.9%35.12%57.98%70.2%-5.93%35.11%-17.16%-248.08%-------
Operating CF Growth %130.08%41.84%159.56%46.68%-32.62%1365.09%94.92%830.68%377.29%87.81%160.74%67.61%-7.81%20.6%-68.82%-6.84%-171.37%-325.11%-60.48%-160.47%
Net Income63.07M54.77M55.93M51.4M79.36M38.33M35.73M45.48M27.18M15.57M932K8.69M80.75M-33.21M-45.3M-32.05M-29.85M-28.11M-49.97M-21.81M
Depreciation & Amortization1.69M1.57M1.73M1.76M1.61M1.54M1.63M1.55M1.53M2.02M1.61M1.51M1.36M1.48M1.31M1.09M975K976K1.01M784K
Stock-Based Compensation13.94M14.16M13.61M13.76M014.12M13.48M13.36M13.32M13.16M9.3M9.85M8.31M11.33M10.44M9.55M9.06M8.19M6.43M5.14M
Deferred Taxes0001.83M-24.68M000000-46.3M0000000-2.05M
Other Non-Cash Items-1.74M1.39M-4.89M-752K11.24M-1.76M-1.34M-1.89M-1.36M-1.62M-2.25M44.73M-102.16M-1.97M-1.41M-488K-36K-31K-135K2.05M
Working Capital Changes14.29M2.91M14.01M9.5M-27.88M494K-18.54M-5.66M18.2M-33.29M6.3M-25.71M-9.49M-11.82M8.81M-430K164K-24.09M27.16M-5.02M
Change in Receivables5.43M-11.97M58K2.49M-17.92M-8.18M1.49M-7.45M5.94M-56.77M-4.43M-32.72M-9.32M0000000
Change in Inventory-2M-958K-243K-1.06M-4.71M880K-1.4M-6.52M-3.68M530K-2.24M-492K-3.08M-906K000000
Change in Payables215K3.06M1.02M-183K-4.02M4.12M906K-591K91K784K727K-222K-360K374K107K-938K-340K578K-554K937K
Cash from Investing-57.98M-161.58M-63.58M11.16M-4.29M-10.53M-54.77M-83.78M-34.33M-19.35M-25.98M-10.16M105.19M-15.96M3.56M-5.21M-14.74M-38.22M-55.91M-126.54M
Capital Expenditures-996K-3.56M-7.15M-2.14M-1.7M-1.9M-6.2M-801K-1.05M-1.13M-1.26M-1.85M-1.78M-2.79M-5.38M-5.22M-14.06M-16.52M-17.19M-40.88M
CapEx % of Revenue0.78%2.99%6.14%2%1.74%1.98%7.04%0.88%1.25%1.61%2.78%4.38%20.82%-------
Acquisitions00000000000000000000
Investments--------------------
Other Investing000000435K00000100M0000000
Cash from Financing3.41M15.05M-10.46M15.67M3.71M1.8M-12.47M2.43M3.37M10.64M10.58M2.62M13.39M185.27M1.47M3.07M2.12M30.7M-542K202.07M
Debt Issued (Net)00000000000000000000
Equity Issued (Net)3.42M15.05M-10.46M15.69M3.71M1.8M1.46M2.43M3.37M10.64M15.97M2.62M-122K185.27M2.22M3.07M2.12M30.7M107K202.07M
Dividends Paid00000000000000000000
Share Repurchases0-108K-16.96M00000000000000000
Other Financing-11K00-23K-5K0-13.93M000-5.39M013.51M0-749K000-649K0
Net Change in Cash35.1M-73.57M5.01M103.7M38.77M45.06M-36.09M-29.1M28.18M-13.22M678K-14.91M97.37M135.13M-21.16M-24.51M-32.31M-50.58M-71.94M54.63M
Free Cash Flow90.25M71.22M73.23M75.37M37.95M50.83M24.77M52.04M57.81M-5.3M14.63M-9.08M-23.01M-36.98M-31.54M-27.55M-33.74M-59.57M-32.68M-61.78M
FCF Margin %70.88%59.74%62.94%70.37%38.81%52.92%28.08%57.1%68.95%-7.54%32.33%-21.54%-268.9%-------
FCF Growth %137.79%40.14%195.72%44.82%-34.35%1059.14%69.3%673.21%351.28%85.67%146.38%67.04%31.82%37.93%3.51%55.41%-19.46%-321.97%-169.51%-305.64%
FCF per Share2.932.322.402.521.271.710.831.741.93-0.180.50-0.32-0.80-1.39-1.23-1.08-1.32-2.33-1.30-2.78
FCF Conversion (FCF/Net Income)1.45x1.37x1.44x1.51x0.50x1.38x0.87x1.16x2.17x-0.27x17.05x-0.83x-0.26x1.03x0.58x0.70x0.66x1.53x0.31x0.96x
Interest Paid00000000000000000000
Taxes Paid0-627K0018K13.46M400K515K3.15M2M0000000000